SAFETY ALERTS FOR MEDICINES AND ALLIED SUBSTANCES.

While medicines and vaccines are studied in well controlled clinical trials and reviewed by regulatory authorities with the aim of ensuring benefits outweigh risks, some adverse effects are observed only once the product is authorized by regulators and used by a larger population in real world conditions. It is therefore essential that medical products continue to be monitored for their effectiveness and safety post release.

PARTNERS

Ministry of Health
World Health Organisation - WHO
HPCZ
NHRA
Pharmaceutical Society of Zambia
ZAMMSA